Delta Air Lines Inc. (NYSE:DAL) on May 1 will lay off 120 employees from its cargo operations at Cincinnati-Northern Kentucky International Airport (CVG), as well as cutting hours for 185 additional cargo workers.
Delta Air Lines, Inc. (NYSE:DAL) belongs to Services sector. Its net profit margin is 11.10% and weekly performance is -0.80%. On last trading day company shares ended up at $48.55. Delta Air Lines, Inc. (NYSE:DAL) distance from 50-day simple moving average (SMA50) is 3.69%.
On 21st February, Fate Therapeutics, Inc. (NASDAQ:FATE), announced that it will present preclinical anti-tumor data for ProTmune™, its lead product candidate for the prevention of acute graft-versus-host-disease (GvHD) and cytomegalovirus (CMV) infection in patients undergoing mobilized peripheral blood (mPB) hematopoietic cell transplantation (HCT), at the BMT Tandem Meetings in Honolulu, Hawaii. The Company’s investigational new drug application for ProTmune was cleared by the U.S. Food and Drug Administration in January 2016, and Fate Therapeutics plans to initiate enrollment of a multi-center, randomized, controlled Phase 1/2 clinical trial in adult patients with hematologic malignancies in mid-2016.
Fate Therapeutics, Inc. (NASDAQ:FATE) shares moved up 0.59% in last trading session and ended the day at $1.70. FATE return on assets is -45.10%. Fate Therapeutics, Inc. (NASDAQ:FATE) quarterly performance is -59.43%.
Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) announced the voluntary nationwide recall of one lot of Fluconazole Injection, USP, (in 0.9% Sodium Chloride) 200mg per 100mL flexible container bag (NDC 25021-113-82) Lot 40608 manufactured by ACS Dobfar INFO S.A. and distributed by Sagent. Sagent has initiated this voluntary recall of Fluconazole Injection, USP, 200mg per 100mL to the user level due to the discovery of an out of specification impurity result detected during routine quality testing of stability samples at the 18-month interval. This impurity has been identified as Metronidazole.
On 02 March, Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) shares moved up 2.86% and was closed at $14.04. SGNT EPS growth in last 5 year was 20.70%. Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) year to date (YTD) performance is -11.75%.
Netlist (NASDAQ: NLST) reported Q4 EPS of ($0.09), $0.06 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $2.9 million versus the consensus estimate of $3.2 million.
Netlist Inc. (NASDAQ:NLST) ended the last trading day at $1.16. Company weekly volatility is calculated as 7.51% and price to cash ratio as 4.64. Netlist Inc. (NASDAQ:NLST) showed a weekly performance of -4.13%.
American Public Education (NASDAQ: APEI) reported Q4 EPS of $0.75, $0.21 better than the analyst estimate of $0.54. Revenue for the quarter came in at $85.9 million versus the consensus estimate of $84.1 million.
American Public Education, Inc. (NASDAQ:APEI) shares increased 2.98% in last trading session and ended the day at $19.37. APEI Gross Margin is 63.80% and its return on assets is 11.50%. American Public Education, Inc. (NASDAQ:APEI) quarterly performance is -16.76%.